Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Khuri

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antisense approaches enter the clinicF R Khuri, J M Kurie
Seminars in Surgical Oncology|February 5, 2000
Lung cancer chemopreventionF R Khuri, S M Lippman
Endocrine-Related Cancer|May 28, 2004
Farnesyl transferase inhibitors: the next targeted therapies for breast cancer?R M O'Regan, F R Khuri
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1996
Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol estersF R Khuri, Y Cho, D A Talmage
Hematology/Oncology Clinics of North America|June 1, 1997
Chemoprevention of respiratory tract cancerF R Khuri, J M Kurie, W K Hong
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 6, 2004
A qualitative study of head and neck cancerR J Moore, R M Chamberlain, F R Khuri
Expert Review of Anticancer Therapy|July 13, 2002
Recent advances in the management of squamous cell carcinoma of the head and neckK B Kim, F R Khuri, D M Shin
Chest Surgery Clinics of North America|November 25, 2000
Prevention of lung cancer. The new millenniumE S Kim, W K Hong, F R Khuri
Current Opinion in Oncology|October 24, 2001
Epidermal growth factor receptor biology (IMC-C225)E S Kim, F R Khuri, R S Herbst
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Emerging therapies in non-small-cell lung cancerF R Khuri, R S Herbst, F V Fossella
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antisense approaches enter the clinicF R Khuri, J M Kurie
Seminars in Surgical Oncology|February 5, 2000
Lung cancer chemopreventionF R Khuri, S M Lippman
Endocrine-Related Cancer|May 28, 2004
Farnesyl transferase inhibitors: the next targeted therapies for breast cancer?R M O'Regan, F R Khuri
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1996
Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol estersF R Khuri, Y Cho, D A Talmage
Hematology/Oncology Clinics of North America|June 1, 1997
Chemoprevention of respiratory tract cancerF R Khuri, J M Kurie, W K Hong
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 6, 2004
A qualitative study of head and neck cancerR J Moore, R M Chamberlain, F R Khuri
Expert Review of Anticancer Therapy|July 13, 2002
Recent advances in the management of squamous cell carcinoma of the head and neckK B Kim, F R Khuri, D M Shin
Chest Surgery Clinics of North America|November 25, 2000
Prevention of lung cancer. The new millenniumE S Kim, W K Hong, F R Khuri
Current Opinion in Oncology|October 24, 2001
Epidermal growth factor receptor biology (IMC-C225)E S Kim, F R Khuri, R S Herbst
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Emerging therapies in non-small-cell lung cancerF R Khuri, R S Herbst, F V Fossella
Pageof 7